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Nielsen J, Mogensen M, Vind BF, Sahlin K, Højlund K,
Schrøder HD, Ørtenblad N. Increased subsarcolemmal lipids in type
2 diabetes: effect of training on localization of lipids, mitochondria,
and glycogen in sedentary human skeletal muscle. Am J Physiol
Endocrinol Metab 298: E706–E713, 2010. First published December
22, 2009; doi:10.1152/ajpendo.00692.2009.—The purpose of the
study was to investigate the effect of aerobic training and type 2
diabetes on intramyocellular localization of lipids, mitochondria, and
glycogen. Obese type 2 diabetic patients (n  12) and matched obese
controls (n  12) participated in aerobic cycling training for 10 wk.
Endurance-trained athletes (n  15) were included for comparison.
Insulin action was determined by euglycemic-hyperinsulinemic
clamp. Intramyocellular contents of lipids, mitochondria, and glyco-
gen at different subcellular compartments were assessed by transmis-
sion electron microscopy in biopsies obtained from vastus lateralis
muscle. Type 2 diabetic patients were more insulin resistant than
obese controls and had threefold higher volume of subsarcolemmal
(SS) lipids compared with obese controls and endurance-trained
subjects. No difference was found in intermyofibrillar lipids. Impor-
tantly, following aerobic training, this excess SS lipid volume was
lowered by50%, approaching the levels observed in the nondiabetic
subjects. A strong inverse association between insulin sensitivity and
SS lipid volume was found (r20.62, P 0.002). The volume density
and localization of mitochondria and glycogen were the same in type
2 diabetic patients and control subjects, and showed in parallel with
improved insulin sensitivity a similar increase in response to training,
however, with a more pronounced increase in SS mitochondria and SS
glycogen than in other localizations. In conclusion, this study, esti-
mating intramyocellular localization of lipids, mitochondria, and gly-
cogen, indicates that type 2 diabetic patients may be exposed to
increased levels of SS lipids. Thus consideration of cell compartmen-
tation may advance the understanding of the role of lipids in muscle
function and type 2 diabetes.
cell compartmentation; transmission electron microscopy; insulin sen-
sitivity
INTRAMYOCELLULAR LIPID (IMCL) accumulation in skeletal mus-
cle of humans has been related to impaired insulin sensitivity
(20, 30). The causality has been challenged by reports of
increased IMCL levels in endurance-trained athletes compared
with untrained (8) and higher IMCL levels in women than in
men without concomitant differences in insulin sensitivity (11,
17). Thus many have suggested that high IMCL levels per se
do not influence insulin sensitivity but represent a marker of
increased fatty acid metabolites such as diacylglycerol (DAG),
ceramide, and long-chain acyl-CoAs, which in turn could be
detrimental for insulin sensitivity (17, 28, 31).
However, evaluation of the role of IMCL in subcellular
fractions has not been considered in previous studies (8, 11, 20,
30). The muscle cell consists mainly of contractile filaments
arranged in myofibrils with mitochondria, lipids, glycogen,
sarcoplasmatic reticulum, and the t-system surrounding the
myofibrils, creating an intermyofibrillar (IMF) space. Further-
more, immediately beneath the sarcolemma, mitochondria,
lipids, glycogen, and nuclei are found in a subsarcolemmal
(SS) space. To our knowledge, no papers have used transmis-
sion electron microscopy (TEM) to assess whether differences
in the content of IMF and SS lipids are present in insulin-
resistant conditions.
Several physiological processes have been shown to be
compartmentalized in skeletal muscle. With differential cen-
trifugation, IMF and SS mitochondria have been fractionated,
and distinct biochemical and physiological properties have
been shown (1, 6, 40). Moreover, morphological analyses have
shown that the content of SS mitochondria is increased more
than IMF mitochondria following endurance training (13).
Advances in confocal imaging techniques have revealed com-
partmentalized GLUT4 translocation, where GLUT4 vesicle
movement of longer distances only took place in the SS region
(21), and a high-fat-fed diet reduced GLUT4 translocation in
the t-system to a greater extent than in the sarcolemma (22).
Furthermore, in carbohydrate metabolism, localization depen-
dency has been found regarding glycogen synthase activity
(34), rate of glycogen resyntheses after exercise (25), and role
of glycogen in single fiber contractility (29). Thus, in skeletal
muscle, the subcellular localization of key proteins involved in
the insulin signaling cascade and energy metabolism has
proven to be important for normal muscle function.
Improvement of insulin sensitivity in type 2 diabetic patients
can be achieved by regular physical activity (42). Therefore,
endurance training of type 2 diabetic subjects is an experimen-
tal model capable of unraveling factors implicated in impaired
insulin sensitivity. Thus, to discover whether compartmental-
ization of energy stores and mitochondria are factors related to
insulin sensitivity, we aimed to estimate the content of lipids,
glycogen, and mitochondria in IMF and SS regions of muscle
fibers obtained from type 2 diabetic patients and body mass
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index (BMI)-matched control subjects pre- and post-10 wk of
aerobic training. We hypothesized that 10 wk of aerobic
training would increase the content of mitochondria and gly-
cogen and decrease the content of lipids in the SS region to a
greater extent than in the IMF region.
MATERIALS AND METHODS
Subjects. Twelve male type 2 diabetic subjects and 12 male age-
and BMI-matched subjects were included in the study (Table 1). Other
aspects of the study have recently been published (27). The control
subjects had no family history of type 2 diabetes, and none was taking
medication. In the diabetic group, six were taking metformin, one was
taking sulfonyluria, and four were taking both drugs. None was
treated with insulin. Seven were treated with antihypertensives and six
with lipid-lowering agents. All medications were withdrawn 7 days
before the pre- and posttraining clamp studies (see below) including
muscle biopsies. Patients were all glutamic acid decarboxylase 65
antibody negative and without signs of diabetic retinopathy, neurop-
athy, nephropathy, or macrovascular complications. All subjects had
normal results on blood test screening for hepatic and renal function
and had no cardiovascular disease. All subjects gave written informed
consent, and the study was approved by the local Ethics Committee of
Funen and Vejle County and was performed in accordance with the
Helsinki Declaration. For relevant comparison, unpublished data from
control biopsies from elite Norwegian cross country skiers [n  10;
maximal oxygen uptake (V˙ O2 max)  68.5  1.5 ml ·min1 ·kg1;
age: 22  0.5 yr; weight: 80.2  2.8 kg; BMI: 24.3  0.5] and
high-level soccer players (n  5; V˙ O2 max  53.1  2.0
ml·min1·kg1; age: 27 1.5 yr; weight: 79.0 3.1 kg; BMI: 24.5 0.6)
were included in the study.
Training program. The subjects participated in an aerobic training
program for 10 wk. The training consisted of cycling on stationary
bikes including sessions of both continuous and interval exercise of
20–30 min of duration four to five times per week. Training intensity
was in the first 6 wk 63  1% and in the last 4 wk 70  2% of
pretraining V˙ O2 max. Details of the training program and compliance
have been reported previously (27).
Test protocols. Before and after training, subjects performed a
graded maximal exercise test to determine V˙ O2 max and underwent a
euglycemic-hyperinsulinemic clamp test (3-h insulin infusion, 80
mU·min1 ·m2) to assess insulin-stimulated glucose disappearance
rate (Rd) as described previously (27). The tests were conducted on
separate days, and the subjects were instructed to abstain from
physical training and strenuous physical activity 48 h before the tests.
Plasma glucose, glycated hemoglobin (HbA1c), serum insulin, free
fatty acid, cholesterol, triglycerides, low density lipoprotein, and high
density lipoprotein were measured as described previously (12).
Muscle biopsies were obtained from the vastus lateralis muscle on the
day of the clamp test before insulin infusion using a modified
Bergström needle with suction under local anesthesia (10 ml lidocaine
2% injected sc).
Transmission electron microscopy. Muscle specimens were fixed
with 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.3)
for 24 h and afterwards rinsed four times in 0.1 M sodium cacodylate
buffer. Following rinsing, muscle specimens were postfixed with 1%
osmium tetroxide and 1.5% potassium ferrocyanide in 0.1 M sodium
cacodylate buffer for 90 min at 4°C. The use of reduced osmium
tetroxide containing potassium ferrocyanide is favoring a high elec-
tron density of glycogen particles (7). After postfixation, the muscle
specimens were rinsed two times in 0.1 M sodium cacodylate buffer
at 4°C, dehydrated through a graded series of alcohol at 4–20°C,
infiltrated with graded mixtures of propylene oxide and Epon at 20°C,
and embedded in 100% Epon at 30°C. To obtain as many fibers as
possible, the ultra-thin sections were cut (using a Leica Ultracut UCT
ultramicrotome) in three depths separated by 150 nm. The sections
were contrasted with uranyl acetate and lead citrate and examined and
photographed in a precalibrated Philips EM 208 electron microscope
and a Megaview III FW camera. In the sections from the three depths
of each biopsy, all of the longitudinally oriented fibers were included
obtaining a mean of nine fibers per biopsy (range: 6–11). From each
fiber, 24 images were obtained at 40,000 magnification in a ran-
domized systematic order, including 12 from the SS region and 6 from
both the superficial and central region of the myofibrillar space (Fig. 1).
The variation in the parameters between images was used to estimate
a coefficient of error (CEest) as proposed for stereological ratio-
estimates by Howard and Reed (15).
Lipid, mitochondria, and glycogen volume and localization. The
following two pools of IMCL were defined: IMF lipids and SS lipids
(Fig. 2). Point counting (9) was used to estimate the IMF lipid volume
density of the myofibrillar space and the SS lipids as a volume per
surface area of fiber. Thus the estimate of SS lipids is unbiased of
training-induced changes in other parameters as mitochondria and
glycogen volume. The CEest was 0.48 and 0.37 for IMF and SS lipid
volume fractions, respectively. The volume of mitochondria was
estimated by point counting. The following three localizations were
defined: central IMF, superficial IMF, and SS (Fig. 1). The IMF
mitochondria were expressed relative to the myofibrillar space and the
Table 1. Subject characteristics
Pretraining Posttraining
Type 2 diabetes Control Type 2 diabetes Control
Age, yr 53  1 53  2
Weight,a kg 108.2  2.2 110.3  3.8 108.0  1.9 108.3  3.8b
BMI,a kg/m2 33.5  1.0 33.2  0.7 33.4  1.0 32.6  0.8b
Body fat, % 31.8  1.8 32.0  1.4 31.1  1.5c 30.2  1.3c
V˙ O2max, ml ·min1 · kg1 27  1 28  2 30  1c 34  2c,d
Fasting plasma glucose, mmol/l 9.6  0.5e 5.8  0.1 9.2  0.5e 5.5  0.1
Fasting serum insulin, pmol/l 82  12 62  7 78  13c 50  4c
Fasting serum FFA, mol/l 503  47 383  34 466  49 420  24
Triglycerides, mmol/l 2.4  0.3e 1.7  0.2 2.4  0.3e 1.5  0.2f
Cholesterol, mmol/l 5.0  0.2 5.4  0.2 4.8  0.2 5.2  0.1f
HDL cholesterol, mmol/l 1.1  0.1 1.2  0.1 1.1  0.1 1.2  0.1f
LDL cholesterol, mmol/l 2.8  0.2e,f 3.4  0.2 2.8  0.2e 3.4  0.1f
HbA1c,a % 7.3  0.3e 5.2  0.1 7.0  0.3b,e 5.3  0.1
Rd, mg ·min1 ·m2 207  28e 332  23 242  30c,e 407  36c
Values are means  SE; n  12 subjects. BMI, body mass index; V˙ O2max, maximal oxygen uptake; FFA, free fatty acid; HDL, high density lipoprotein; LDL,
low density lipoprotein; HbA1c, glycated hemoglobin; Rd, insulin-stimulated rate of glucose disappearance. aInteraction of training and group (P  0.01);
bdifferent from pretraining (P  0.05); cmain effect of training (P  0.05); dn  10; emain effect of group (P  0.05); fn  11.
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SS mitochondria relative to the surface area of fiber. The CEest were
0.25, 0.28, and 0.27 for central IMF, superficial IMF, and SS mito-
chondria, respectively. The following three localizations of glycogen
in the fibers were defined (Fig. 2): 1) the IMF space, 2) the intramyo-
fibrillar space (inside the myofibrils, between the contractile fila-
ments), and 3) the SS space. The glycogen volume fraction (VV) in
each location was estimated as proposed by Weibel (eq. 4.20 in Ref.
43), where the effect of section thickness was taken into account:
VV  AA  t {(1/)BA  NA[(t ·H)/(t 	 H)]}, where AA is the
glycogen area fraction, t is the section thickness (60 nm), BA is the
glycogen boundary length density, NA is the number of particles per
area, and H is the average glycogen profile diameter. It was assumed
that the particles were spherical (26). The glycogen area fraction was
estimated by point counting, and the average glycogen profile diam-
eter was directly measured using iTEM (FEI). The IMF glycogen was
expressed as relative to the myofibrillar space, the intramyofibrillar
glycogen to the intramyofibrillar space, and SS glycogen to the
surface area. The CEest were 0.09, 0.10, and 0.17 in IMF, intramyo-
fibrillar, and SS glycogen, respectively. The low CEest values for the
glycogen estimates allowed us to obtain information at the fiber level;
thus, fiber type differences were addressed by classifying all the fibers
as type I or II based on a combination of IMF mitochondrial volume
and Z-line width (38). To achieve two pools of different fiber types,
the intermediate fibers were discarded, and only the three most
extreme fibers of each type were included. In general, when the
distribution of the individual fractions is expressed relative to the total
content, the fibers were assumed to be of cylindrical shape with a
diameter of 80 m (36). Since IMF and intramyofibrillar fractions
are expressed as volume densities and SS fractions as volume per
fiber surface area, total values were obtained by recalculating the
IMF and intramyofibrillar fractions to volume per fiber surface
area. Assuming fibers of cylindrical shape, the volume beneath the
surface area of fiber (Vb) is: Vb  R · 0.5 · A, where R is fiber
radius and A is the fiber surface area. When fiber radius is assumed
to be 40 m and fiber surface area is 1 m2, the volume beneath
the surface area of fiber is 20 m3. Thus the volume fractions of
IMF and intramyofibrillar parameters are multiplied with a factor
of 20 when relative comparison with SS parameters is conducted
and total values are calculated.
Statistics. Statistical analyses were performed using STATA 10.1
(Stata Statistical Software: Release 10; StataCorp, College Station,
TX). All interactions or main effects were tested using a linear
mixed-effects model with subjects as random effect and with training,
group, and location as fixed effects. Variables with skewed distribu-
tions were log-transformed before analysis. When data did not reach
normal distribution and equal variance, the nonparametric Kruskal-
Wallis test was used. Relationships between continuous variables
were investigated using Pearson’s correlation analysis. Significance
level was accepted at P  0.05.
RESULTS
A comprehensive description of the subjects is presented in
Table 1 and can also be found in a companion paper (27).
Briefly, type 2 diabetic patients had higher HbA1c, fasting
glucose, and plasma triglyceride levels and lower insulin sen-
sitivity compared with control subjects (Table 1). Training
induced an 20% increase in insulin sensitivity in both groups
and a slight but significant decrease in HbA1c in type 2 diabetic
patients (Table 1).
IMCL localization. Median [interquartile range (IQR)] total
volume percentages of IMCL in type 2 diabetic patients was
Fig. 2. Skeletal muscle intramyocellular lipid, glycogen, and mitochondria.
TEM images of the subsarcolemmal region (A) and myofibrillar region (B) of
skeletal muscle fiber (original magnification 40,000, scale bar  0.5 m). L,
lipid droplet; M, mitochondria; G, glycogen particles (black dots); Z, Z-line. In
A, white arrow indicates sarcolemma. In B, glycogen is located both in the
intermyofibrillar (IMF) space (white G) and intramyofibrillar space (black G).
These images, illustrating the two distinct compartments, are from a type 2
diabetic patient pretraining (A) and posttraining (B).
Fig. 1. Location of transmission electron microscopy (TEM) images. The
location of TEM images was systematically randomized representing the
subsarcolemmal region (S), the superficial myofibrillar region (sM), and
the central myofibrillar region (cM) of each fiber. Twelve images were
obtained from the subsarcolemmal region and 6 from both the superficial and
central myofibrillar regions (original 1,600 magnification, scale bar  4 m).
This particular image is from a cross country skier.
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0.66 (0.36–1.43) pretraining and 0.65 (0.37–1.24) posttraining.
Lower values were observed in control subjects: 0.33 (0.28–
0.58) pretraining and 0.35 (0.28–0.87) posttraining (main
effect, P  0.03). Training did not change the total volume
percentage of IMCL (P  0.80), and no interaction with group
of subjects was found (P  0.24). Corresponding values were
in elite cross country skiers [0.52 (0.37–0.85)] and in soccer
players [0.42 (0.24–0.82)], which were not different from type
2 diabetic patients and control subjects (P  0.25).
Two subcellular fractions of IMCL were defined based on
their localization in either the SS or IMF space. This revealed
that type 2 diabetic patients had a 3.1-fold higher level of SS
lipids in the pretraining condition compared with control sub-
jects (P  0.002) and endurance-trained subjects (P  0.007),
whereas no differences in IMF lipids among groups were found
(P  0.43) (Fig. 3A). Moreover, training decreased (45%, P 
0.03) the level of SS lipids in type 2 diabetic patients (Fig. 3A),
thus approaching the levels observed in controls. Expressed
relative to total IMCL volume, type 2 diabetic patients also had
increased levels of SS lipids pretraining (Fig. 3B).
Correlation analysis showed a strong inverse relationship
between pretraining levels of SS lipids and insulin sensitivity
measured as Rd (r2  0.62, P  0.002; Fig. 4). No such
relationship was observed in control subjects (r2  0.05, P 
0.51). The pretraining level of IMF lipids tended to be in-
versely related to insulin sensitivity in both type 2 diabetic
patients (r2  0.29, P  0.07) and control subjects (r2  0.26,
P 0.09). Regarding pretraining total lipid volume, an inverse
relationship with insulin sensitivity was found in type 2 dia-
betic patients (r2  0.42, P  0.02), and a tendency was found
in control subjects (r2  0.27, P  0.08). No relationships
between fractions of lipids and insulin sensitivity were ob-
served posttraining or when using delta values (post-pre val-
ues).
Mitochondria. Control subjects and type 2 diabetic patients
had an equal volume fraction of total mitochondria pretraining,
Fig. 3. Subfractions of intramyocellular lipid
(IMCL) in type 2 diabetes. A: two fractions of
IMCL [top, IMF lipids; bottom, subsarcolemmal
(SS) lipids] in type 2 diabetic patients and body
mass index (BMI)-matched controls pre- and
post-10 wk of aerobic training compared with
high-level soccer players and elite cross country
skiiers. A 3-way interaction of training, location,
and group was found (P  0.02). †P  0.05 vs.
type 2 diabetes pretraining. Each point represents
one individual; the horizontal lines indicate median
values. B: box and whisker plot, as medians, inter-
quartile range, adjacent values, and outliers (open
circles), showing the relative contribution of SS
lipids to total IMCL in different groups and situa-
tions. A main effect of group was found (P 
0.0001). P  0.05 vs. type 2 diabetes pretraining
(†) and posttraining (‡).
Fig. 4. Relationship between insulin sensitivity and intramuscular SS lipids. ●,
Type 2 diabetic patients pretraining; ‘ with SE bars, mean value of control
subjects pretraining; line, linear regression line of prevalues from type 2
diabetic patients best fitted by the equation y  31117x 	 321 (r2  0.62,
P  0.002). Inset: addition posttraining values (Œ). The thin lines connect
individual pre and post values. No association between post values of SS lipids
and insulin sensitivity was found (P  0.43).
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and the training mediated an increase (40%) of similar
magnitude in both groups (Table 2). TEM revealed distinct
compartments and regions of mitochondria in muscle fibers.
Concerning mitochondria volume, there was no difference
between type 2 diabetic patients and control subjects in either
of these localizations (Table 2). In relative terms (median and
IQR), 10.6% (9.1–12.6) of the total mitochondria were local-
ized in the SS region, 68.9% (65.3–73.8) in the superficial IMF
region, and 17.5% (14.2–22.9) in the central IMF region. The
training-mediated increase was dependent on localization (P
0.001) and not different between groups (P  0.36). Post hoc
analysis revealed that the relative increase in median SS
mitochondria (124%) was greater than in both superficial IMF
(64%) and central IMF (14%) mitochondria (P 0.02 and P
0.001, respectively). The increments in central and superficial
IMF mitochondria were not different (P  0.10). No associa-
tions between mitochondria volume and insulin sensitivity
could be detected.
Glycogen. As with mitochondria, the type 2 diabetic patients
had volume fraction of total glycogen pretraining equal to
control subjects, and the training mediated an increase (25%)
of similar magnitude in both groups (Table 2). The glycogen
volume was estimated in three distinct localizations. The rel-
ative distribution was not different between groups, pretraining
values (median and IQR) were 84.4% (81.5–87.2) as IMF
glycogen, 8.6% (6.0–11.1) as intramyofibrillar glycogen, and
6.8% (5.3–8.3) as SS glycogen. The increase in glycogen
following training was not different between groups (P 
0.78); however, there was a localization effect (P  0.0001).
Post hoc analysis showed that the median relative increase in
SS glycogen (91%) was greater compared with the increase in
IMF (14%) and intramyofibrillar glycogen (15%) (P  0.0004
and P 0.002, respectively), whereas no difference was found
between the relative increments in IMF and intramyofibrillar
glycogen (P  0.50).
The average  SE particle volume of glycogen increased
(23%) from 13,619  431 nm3 (diameter of 29.5  0.3 nm)
pretraining to 16,660  470 nm3 (diameter of 31.6  0.3 nm)
posttraining. Glycogen volume in none of the three localiza-
tions was associated with insulin sensitivity. Discrimination
between type I and II fibers based on the mitochondrial volume
density and Z-line width revealed that no fiber type differences
were present in any of the three localizations of glycogen (data
not shown). This was observed in type 2 diabetic patients and
control subjects both before and after training.
DISCUSSION
Patients with type 2 diabetes have altered fat metabolism
with elevated lipid metabolites in blood and tissues, which has
been linked to decreased insulin sensitivity. The high magni-
fication of TEM allows visualization of intramuscular lipid
droplets, revealing that lipid droplets are localized in the fibers
both just beneath the sarcolemma, a SS fraction, and in be-
tween the myofibrils throughout the interior of the fiber, an
IMF fraction. This study is, to our knowledge, the first using
electron microscopy to address the role of these two distinct
fractions of IMCL in type 2 diabetes and training. Three novel
aspects were discovered: 1) an abnormal lipid distribution with
threefold higher volume of lipids in the SS region and similar
volume density of IMF lipids in sedentary type 2 diabetic
patients compared with BMI-matched control subjects and
highly endurance trained subjects; 2) a strong inverse relation-
ship between pretraining levels of SS lipid and insulin sensi-
tivity in type 2 diabetic subjects; and 3) an aerobic training-
mediated decrease in SS lipids of type 2 diabetic patients
approaching the levels of control subjects. Together, this dem-
onstrates an abnormality of SS lipids in type 2 diabetes, which
could be an important factor contributing to the regulation of
skeletal muscle insulin sensitivity.
The present data confirm previous reports (8, 23) showing
that type 2 diabetic subjects have higher total IMCL content
compared with BMI-matched control subjects. Endurance
training has previously been shown to lower the content of
IMCL in type 2 diabetic patients (4, 19). However, in nondi-
abetic untrained subjects, endurance training often elevates the
IMCL content (10, 14, 18, 33). These increments in total IMCL
seems to be achieved after training periods at medium intensity
(60% of maximal oxygen uptake) with sessions exceeding 1 h
in duration (18, 33). One study with sessions of higher intensity
(72%) and shorter duration (30 min) found only an increase in
type II fibers (14). Furthermore, a study with varying intensity
Table 2. Effect of 10 wk of aerobic training on mitochondria and glycogen in different subcellular locations
Pretraining Posttraining
Type 2 diabetes Control Type 2 diabetes Control
Mitochondria
Total, m3/m3 fiber 0.051 (0.038–0.063) 0.045 (0.042–0.057) 0.068 (0.059–0.083)a,b 0.068 (0.058–0.086)a
IMF central, m3m3 myofibrillar space 0.037 (0.027–0.042) 0.037 (0.032–0.041) 0.044 (0.029–0.057)b 0.046 (0.037–0.059)
IMF superficial, m3/m3 myofibrillar
space
0.048 (0.034–0.057) 0.042 (0.035–0.052) 0.065 (0.059–0.075)b 0.064 (0.052–0.076)
SS, m3/m2 fiber surface area 0.100 (0.072–0.170) 0.101 (0.086–0.138) 0.212 (0.150–0.275)b,c 0.203 (0.156–0.251)c
Glycogen
Total, m3/m3 fiber 0.035 (0.033–0.037) 0.028 (0.024–0.034) 0.041 (0.035–0.048)a,d 0.038 (0.037–0.043)a,d
IMF, m3/m3 myofibrillar space 0.029 (0.028–0.031) 0.024 (0.021–0.029) 0.033 (0.029–0.040)d 0.032 (0.029–0.036)d
Intramyofibrillar, m3/m3 intramyofibrillar
space
0.0045 (0.0025–0.0049) 0.0031 (0.0026–0.0033) 0.0043 (0.0033–0.0048)d 0.0036 (0.0030–0.0044)d
SS, m3/m2 fiber surface area 0.053 (0.041–0.062) 0.035 (0.026–0.051) 0.083 (0.060–0.101)c,d 0.080 (0.070–0.088)c,d
Values are medians with IQR in parentheses; n  12 subjects). IMF, intermyofibrillar; SS, subsarcolemmal. aMain effect of training (P  0.05); cinteraction
of training and location (P  0.0001): post hoc, training effect greater in SS compared with the other locations (P  0.05);.bn  11; dn  10.
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(65–85%) and 1-h sessions found only an increase in total
IMCL if the training period included a high-fat diet (10). Thus
it is likely that a combination of the higher training intensity
(62–70%), shorter session duration (30 min), and normal diet
composition explains why total IMCL was not increased fol-
lowing the training period in the present study. However,
importantly, our results suggest that aerobic training has dif-
ferent effects on two distinct fractions of IMCL. We found that
sedentary type 2 diabetic patients had a threefold higher pre-
training level of SS lipids compared with control subjects, and,
although training halved this pool of SS lipids, the IMF lipids
were unchanged. In control subjects, both SS and IMF lipids
were unchanged following training.
Recently, van Loon et al. (41) used fluorescence microscope
and Oil red O staining, a procedure with the lower resolution of
light microscopy, to compare IMCL localization in type 2
diabetic patients with highly endurance-trained athletes and
lean sedentary. In successive bands of 2 m in width from the
sarcolemma toward the central of each fiber, they found no
difference in the relative distribution pattern of lipids between
groups. This is in agreement with a previous study using the
same method on obese subjects before and after endurance
training and diet intervention (24). In spite of different methods
used, it is in contrast to our results showing an accumulation of
SS lipids in type 2 diabetic patients compared with both
BMI-matched controls and highly endurance-trained athletes.
This is likely explained by the insensitivity of the 2-m band
method, used in the two studies, to precisely define and thus
estimate the lipid volume in the SS region. The width of the SS
region depends on the presence of lipids, nuclei, mitochondria,
glycogen, and capillaries in connection to the fiber. Thus, in a
fiber, the width of the SS region can vary from almost zero up
to 10 m in the extreme. A 2-m band could therefore contain
IMF lipids and, likewise, SS lipids could reach deeper than 2
m, confounding the true measure of a SS lipid fraction.
IMCL has been implicated in type 2 diabetes based on
correlation analysis, showing strong negative associations be-
tween total IMCL content and insulin sensitivity in sedentary
subjects (20, 30, 32). However, this association disappears with
the inclusion of endurance-trained subjects, because they have
elevated IMCL levels and, at the same time, are highly insulin
sensitive (8, 16, 41). The contradictions have been termed the
“athlete paradox.” Our results suggesting that the distribution
of IMCL in SS and IMF fractions is different between the
above-mentioned group of subjects provide one explanation for
this contradiction.
Fatty acid metabolites such as DAG and ceramide concen-
trations were recently measured in both a membrane-bound
and a cytosolic fraction when overexpressing carnitine palmi-
toyltransferase-1 in rats (3). This revealed a selective decrease
in the membrane-bound DAG, which was associated with an
inhibition of protein kinase (PKC
), ultimately leading to
improved insulin sensitivity. With the reservation that lipid
localization in rodents could be different from that in humans,
this membrane-bound fraction of DAG could represent a sar-
colemmal pool, supporting our results suggesting a role of
lipids in modulating insulin sensitivity in the SS region.
The higher SS lipid content found in the type 2 diabetic
patients can be explained by elevated lipid availability and/or
diminished SS mitochondria lipid oxidative capacity. The
blood profile with elevated plasma triglycerides indicates ele-
vated lipid availability in the type 2 diabetic patients (Table 1).
There was no difference in SS mitochondria volume between
groups (Table 2); however, this does not necessarily reflect the
lipid oxidation capacity. Lipid oxidation is a complex process
involving several steps, including -oxidation, tricarboxylic
acid cycles, and electron transport chain. Ritov et al. (35)
showed that the electron transport chain activity was sup-
pressed, particularly in SS mitochondria in type 2 diabetic
patients, compared with BMI- and age-matched subjects. A
study using rats showed a lower lipid oxidation rate in SS
mitochondria compared with IMF mitochondria, and that a
modest overexpression of PGC-1 selectively increased the
lipid oxidation rate in SS mitochondria and concomitantly
increased insulin sensitivity (2). If type 2 diabetic patients have
impaired SS mitochondrial lipid oxidation capacity, it can
explain the observed accumulation of SS lipids in these pa-
tients.
The question emerges as to what is the difference between
IMF and SS lipids? The structure of the muscle cell with a
highly developed transverse tubular system (t-system) connect-
ing the interior of the cell with the surface should be recog-
nized. The IMF lipids are often found very close to the
mitochondria in remote positions from the t-system, which is
almost exclusively surrounded by the sarcoplasmatic reticu-
lum. In the SS region, lipids often touch the sarcolemma (Fig. 5),
and in this region the t-system is not surrounded, and may be
protected, by the sarcoplasmatic reticulum. Thus SS lipids
might more easily interfere with key proteins involved in the
insulin signaling cascade than IMF lipids. More detailed in-
sights in the difference between SS and IMF lipids could be
Fig. 5. TEM images of the subsarcolemmal region. TEM images illustrating
the difference in subsarcolemmal lipid accumulation pretraining between type
2 diabetic patients (A) and control subjects (B) (original magnification
13,000, scale bar  2 m). The white circular areas are lipid droplets.
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obtained by intervention studies with inclusion of anti-diabetic
drugs and diet alterations.
Although the decrease in SS lipids was accompanied by
improved insulin sensitivity in type diabetic patients, insulin
sensitivity was still significantly reduced after training while
the difference in SS lipids was abolished compared with obese
control subjects. Moreover, the inverse association between
pretraining levels of SS lipid and insulin sensitivity observed in
type 2 diabetes disappeared following the 10 wk of aerobic
training. This is in accordance with a previous report using
biochemically determined intramuscular triacylglycerol (4).
This can be interpreted as 1) mainly in sedentary subjects, high
SS lipids contribute to impaired insulin sensitivity and 2) excess
amount of SS lipids are not the single cause of impaired insulin
sensitivity; hence, other factors related to impaired insulin
sensitivity (e.g., cytokines and hormones) were not improved.
In the present study, as in the previous work (4), plasma
glucose and triglycerides remained elevated posttraining in the
type 2 diabetic patients and, furthermore, the patients did not
reduce their body mass.
Studies comparing weight-matched, nondiabetic subjects
have shown both lower (5, 23, 37) and equal (39) content of
muscle glycogen in type 2 diabetes. However, recently, we
have demonstrated that distinct subcellular fractions of glyco-
gen have different roles in muscle function (29). Thus we
aimed to investigate the role not only of glycogen content but
also glycogen localization in type 2 diabetes and training.
Although there were no type 2 diabetes-related differences, the
increase in glycogen content following endurance training was
highly localization dependent. The SS glycogen was more than
doubled, whereas IMF and intramyofibrillar glycogen only
increased by 20%. The volume of glycogen particles in-
creased by 23%, which indicates that the increase in IMF and
intramyofibrillar glycogen was accounted for by adding glu-
cose residues to existing particles, in contrast to the increase in
SS glycogen where an increase in the number of particles
might have occurred as well. This is a novel indication of
compartment-dependent biosynthesis of new glycogen parti-
cles. Together with lipids and mitochondria, glycogen adapta-
tions to aerobic training predominantly occur in the SS region,
indicating, in general, a role of proximity to the sarcolemma,
interstitium, and capillary, or a mechanical component related
to proteins exclusively situated in the sarcolemma in aerobic
training adaptations.
In conclusion, this study, estimating intramyocellular local-
ization of lipids, mitochondria, and glycogen using TEM,
indicates that type 2 diabetic patients are exposed to an in-
creased content of lipids localized just beneath the sarco-
lemma. This was found both compared with nondiabetic
matched control subjects and endurance-trained athletes. Inter-
estingly, aerobic training was found to lower this excess SS
lipid content by 50%, approaching the levels observed in the
nondiabetic subjects. Thus consideration of cell compartmen-
tation may advance the understanding of the role of lipids in
muscle function and type 2 diabetes. The distribution and
content of glycogen and mitochondria in different compart-
ments was not different in type 2 diabetic patients compared
with matched control subjects; however, the increase in gly-
cogen content following training indicated a subsarcolemmal
location for new glycogen particle biosynthesis.
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